These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7496088)

  • 41. [A case of RAEB-t treated by G-CSF showing complete remission after MST-16 treatment for subsequent reversible leukemia].
    Murate T; Ohashi H; Kagami Y; Hotta T; Murase T; Hirota Y; Kimura K
    Gan To Kagaku Ryoho; 1991 Sep; 18(12):2155-8. PubMed ID: 1716093
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Proliferative response of human acute myeloid leukemia cells and normal marrow enriched progenitor cells to human recombinant growth factors IL-3, GM-CSF and G-CSF alone and in combination.
    Lemoli RM; Gulati SC; Strife A; Lambek C; Perez A; Clarkson BD
    Leukemia; 1991 May; 5(5):386-91. PubMed ID: 1709711
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Timed-sequential chemotherapy with concomitant granulocyte colony-stimulating factor for newly diagnosed de novo acute myelogenous leukemia.
    He XY; Pohlman B; Lichtin A; Rybicki L; Kalaycio M
    Leukemia; 2003 Jun; 17(6):1078-84. PubMed ID: 12764371
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The levels of granulocyte colony-stimulating factor in the plasma of the bone marrow aspirate in various hematological disorders.
    Shinohara K; Oeda E; Nomiyama J; Inoue H; Kamei S; Tajiri M; Ichikawa T; Kuwaki T; Tachibana K
    Stem Cells; 1995 Jul; 13(4):421-7. PubMed ID: 7549901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Acute myelogenous leukemia with multilineage myelodysplasia, positive direct Coombs test, and elevated levels of platelet-associated IgG].
    Kuroda H; Matsunaga T; Sakamaki S; Koike K; Terui T; Neda H; Ishitani K; Nobuoka A; Kida M; Watanabe H; Niitsu Y
    Rinsho Ketsueki; 2007 May; 48(5):407-11. PubMed ID: 17571587
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clinical effects of recombinant human granulocyte colony-stimulating factor in leukemia patients: a phase I/II study.
    Teshima H; Ishikawa J; Kitayama H; Yamagami T; Hiraoka A; Nakamura H; Shibata H; Masaoka T; Takaku F
    Exp Hematol; 1989 Sep; 17(8):853-8. PubMed ID: 2475358
    [TBL] [Abstract][Full Text] [Related]  

  • 47. GM-CSF and low-dose araC treatment of AML in prolonged hypoplasia with residual leukemic cells after induction chemotherapy.
    Min YH; Kim SE; Lee ST; Lee SJ; Hahn JS; Ko YW
    Yonsei Med J; 1994 Mar; 35(1):91-6. PubMed ID: 8009902
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A pilot study of the biologic and therapeutic effects of granulocyte colony-stimulating factor (filgrastim) in patients with acute myelogenous leukemia.
    Jakubowski A; Gordon M; Tafuri A; Schuster S; Andreeff M; Shieh JH; Vincent M; Gabrilove J
    Leukemia; 1995 Nov; 9(11):1799-804. PubMed ID: 7475265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Remission induction of refractory anaemia with excess blasts in transformation by sole treatment with granulocyte colony-stimulating factor with persistent chromosomal abnormality.
    Kondo H; Kasahara Y; Mori A
    Acta Haematol; 2002; 107(3):177-81. PubMed ID: 11978940
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [The potential prognostic influence of granulocyte-colony stimulating factor in acute leukemia].
    Liu XM; Chen YZ; Huang MJ; Liu X; Guo JR
    Zhonghua Nei Ke Za Zhi; 2005 Jul; 44(7):518-21. PubMed ID: 16080844
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Acute myelogenous leukemia (FAB AML-M1) in the setting of HIV infection and G-CSF therapy: a case report and review of the literature.
    King JA; Nye DM; O'Connor MB; Sendelbach KM; Elkhalifa MY
    Ann Hematol; 1998; 77(1-2):69-73. PubMed ID: 9760157
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Relationship between white blood cell count elevation and clinical response after G-CSF priming chemotherapy for acute myeloid leukemia.
    Minakata D; Fujiwara SI; Ikeda T; Toda Y; Ito S; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Kanda Y
    Int J Hematol; 2017 Sep; 106(3):411-417. PubMed ID: 28508228
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Therapeutic use of granulocyte-colony stimulating factor could conceal residual malignant cells in patients with AML1/ETO+ acute myelogenous leukemia.
    Moon HW; Shin S; Kim HY; Kim YR; Cho HI; Yoon SS; Park S; Kim BK; Chun H; Kim HC; Park CJ; Min YH; Lee DS
    Leukemia; 2006 Aug; 20(8):1408-13. PubMed ID: 16791271
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Prognostic significance of blood and marrow findings in acute myelogenous leukemia in remission. A Southeastern Cancer Study Group report.
    Vogler WR; Raney MR
    Cancer; 1988 Jun; 61(12):2481-6. PubMed ID: 3163256
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Post-remission intensive consolidation with high-dose cytarabine-based chemotherapy and granulocyte colony-stimulatory factor in adults with acute myelogenous leukemia: a preliminary report.
    Hsu HC; Chiu CF; Tan TD; Chau WK; Tseng CS; Ho CH
    Zhonghua Yi Xue Za Zhi (Taipei); 1995 Nov; 56(5):305-11. PubMed ID: 8605644
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Increased serum levels of granulocyte colony-stimulating factor after autologous bone marrow or blood stem cell transplantation.
    Haas R; Gericke G; Witt B; Cayeux S; Hunstein W
    Exp Hematol; 1993 Jan; 21(1):109-13. PubMed ID: 7678083
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Granulocyte-macrophage colony-stimulating factor (GM-CSF), given concurrently with induction therapy for acute myelogenous leukemia (AML), augments the syndrome of T-lymphocyte recovery.
    Gore SD; Donnenberg AD; Zehnbauer BA; Weng LJ; Burke PJ
    Leukemia; 1994 Mar; 8(3):409-19. PubMed ID: 8127146
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hematopoietic growth factors in the treatment of acute leukemia.
    Estey E
    Curr Opin Oncol; 1998 Jan; 10(1):23-30. PubMed ID: 9466481
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Differential effects of TGF-beta 1 on normal and leukemic human hematopoietic cell proliferation.
    Murohashi I; Endho K; Nishida S; Yoshida S; Jinnai I; Bessho M; Hirashima K
    Exp Hematol; 1995 Aug; 23(9):970-7. PubMed ID: 7543418
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Granulocyte-macrophage colony-stimulating factor after initial chemotherapy for elderly patients with primary acute myelogenous leukemia. Cancer and Leukemia Group B.
    Stone RM; Berg DT; George SL; Dodge RK; Paciucci PA; Schulman P; Lee EJ; Moore JO; Powell BL; Schiffer CA
    N Engl J Med; 1995 Jun; 332(25):1671-7. PubMed ID: 7760868
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.